How much is the Blood Glucose Monitoring Devices market?

The blood glucose monitoring devices market size is estimated to grow at $$ 10140 mn in 2024. Read More

What is the growth rate of the Blood Glucose Monitoring Devices market?

The growth rate of the blood glucose monitoring devices year-over-year is 10%. Read More

Which region held the largest market share in the Blood Glucose Monitoring Devices market?

North America is the region to held the largest market share with 45% growth. Read More

Who are the key players in the Blood Glucose Monitoring Devices market?

Abbott Laboratories, ACON Laboratories Inc., Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Atlas Medical GmbH, Dexcom Inc., F. Hoffmann La Roche Ltd., LifeScan .... Read More

Which Segment has the largest market share in the Blood Glucose Monitoring Devices market?

End-user is the segment that has the largest market share in the market. Read More

Blood Glucose Monitoring Devices Market Analysis, Size, and Forecast 2025-2029: North America (US, Canada, and Mexico), Europe (France, Germany, Italy, and UK), APAC (China, India, and Japan), and Rest of World (ROW)

Published: Apr 2025
Pages: 217
SKU: IRTNTR44338

Enjoy complimentary customisation on priority with our Enterprise License!

Blood Glucose Monitoring Devices Market Size 2025-2029

The blood glucose monitoring devices market size is forecast to increase by USD 10.14 billion at a CAGR of 10% between 2024 and 2029.

The market is experiencing significant growth, driven by the rising global burden of diabetes and the increasing adoption of advanced technologies such as smart watch-based apps for continuous glucose monitoring. According to the International Diabetes Foundation, approximately 463 million adults were living with diabetes in 2019, and this number is projected to reach 700 million by 2045. This growing population of diabetes patients presents a substantial market opportunity for blood glucose monitoring device manufacturers. However, the market faces challenges that could hinder its growth potential. Regulatory hurdles impact adoption, as these devices must meet stringent regulatory requirements to ensure accuracy and safety.
Additionally, supply chain inconsistencies can pose challenges, as the demand for these devices is often volatile and requires a reliable and flexible supply chain to meet patient needs effectively. To capitalize on market opportunities and navigate these challenges, companies must focus on regulatory compliance, supply chain optimization, and the development of user-friendly and accurate devices that meet the evolving needs of diabetes patients. Technological advances in this field have led to more sophisticated devices, such as continuous glucose monitoring systems, insulin syringe and pens, which offer enhanced functionality and improved patient outcomes. The hospital end-use segment supports inpatient monitoring, while home healthcare segment devices empower individuals with convenient glucose monitoring solutions. By addressing these challenges, market participants can position themselves for long-term success in the market.

What will be the Size of the Blood Glucose Monitoring Devices Market during the forecast period?

Request Free Sample

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2024

4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Blood Glucose Monitoring Devices Market 2019 - 2023
- Historic Market Size - Data Table on Global Blood Glucose Monitoring Devices Market 2019 - 2023 ($ million)

5.2 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)

5.3 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)

5.4 Indication segment analysis 2019 - 2023
- Historic Market Size - Indication Segment 2019 - 2023 ($ million)

5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)

5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Blood Glucose Monitoring Devices Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029

7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)

8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user

8.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)

8.4 Home care - Market size and forecast 2024-2029
- Chart on Home care - Market size and forecast 2024-2029 ($ million)
- Data Table on Home care - Market size and forecast 2024-2029 ($ million)
- Chart on Home care - Year-over-year growth 2024-2029 (%)
- Data Table on Home care - Year-over-year growth 2024-2029 (%)

8.5 Diagnostic centers - Market size and forecast 2024-2029
- Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)

8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Product

9.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)

9.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product

9.3 SMBG - Market size and forecast 2024-2029
- Chart on SMBG - Market size and forecast 2024-2029 ($ million)
- Data Table on SMBG - Market size and forecast 2024-2029 ($ million)
- Chart on SMBG - Year-over-year growth 2024-2029 (%)
- Data Table on SMBG - Year-over-year growth 2024-2029 (%)

9.4 CGM - Market size and forecast 2024-2029
- Chart on CGM - Market size and forecast 2024-2029 ($ million)
- Data Table on CGM - Market size and forecast 2024-2029 ($ million)
- Chart on CGM - Year-over-year growth 2024-2029 (%)
- Data Table on CGM - Year-over-year growth 2024-2029 (%)

9.5 Lancets - Market size and forecast 2024-2029
- Chart on Lancets - Market size and forecast 2024-2029 ($ million)
- Data Table on Lancets - Market size and forecast 2024-2029 ($ million)
- Chart on Lancets - Year-over-year growth 2024-2029 (%)
- Data Table on Lancets - Year-over-year growth 2024-2029 (%)

9.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

10 Market Segmentation by Indication

10.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)

10.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication

10.3 Type-2 diabetes population - Market size and forecast 2024-2029
- Chart on Type-2 diabetes population - Market size and forecast 2024-2029 ($ million)
- Data Table on Type-2 diabetes population - Market size and forecast 2024-2029 ($ million)
- Chart on Type-2 diabetes population - Year-over-year growth 2024-2029 (%)
- Data Table on Type-2 diabetes population - Year-over-year growth 2024-2029 (%)

10.4 Type-1 diabetes population - Market size and forecast 2024-2029
- Chart on Type-1 diabetes population - Market size and forecast 2024-2029 ($ million)
- Data Table on Type-1 diabetes population - Market size and forecast 2024-2029 ($ million)
- Chart on Type-1 diabetes population - Year-over-year growth 2024-2029 (%)
- Data Table on Type-1 diabetes population - Year-over-year growth 2024-2029 (%)

10.5 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)

12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)

12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)

12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)

12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)

12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)

12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)

12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)

12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)

12.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)

12.12 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)

12.13 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)

12.14 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)

12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)

12.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)

12.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers

13.2 Market challenges

13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview

14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

14.3 Landscape disruption
- Overview on factors of disruption

14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered

15.2 Company ranking index
- Company ranking index

15.3 Market positioning of companies
- Matrix on companies position and classification

15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT

15.5 ACON Laboratories Inc.
- ACON Laboratories Inc. - Overview
- ACON Laboratories Inc. - Product / Service
- ACON Laboratories Inc. - Key offerings
- SWOT

15.6 Agamatrix Inc.
- Agamatrix Inc. - Overview
- Agamatrix Inc. - Product / Service
- Agamatrix Inc. - Key offerings
- SWOT

15.7 ARKRAY Inc.
- ARKRAY Inc. - Overview
- ARKRAY Inc. - Product / Service
- ARKRAY Inc. - Key offerings
- SWOT

15.8 Ascensia Diabetes Care Holdings AG
- Ascensia Diabetes Care Holdings AG - Overview
- Ascensia Diabetes Care Holdings AG - Product / Service
- Ascensia Diabetes Care Holdings AG - Key offerings
- SWOT

15.9 Dexcom Inc.
- Dexcom Inc. - Overview
- Dexcom Inc. - Product / Service
- Dexcom Inc. - Key offerings
- SWOT

15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT

15.11 LifeScan IP Holdings LLC
- LifeScan IP Holdings LLC - Overview
- LifeScan IP Holdings LLC - Product / Service
- LifeScan IP Holdings LLC - Key offerings
- SWOT

15.12 medisana GmbH
- medisana GmbH - Overview
- medisana GmbH - Product / Service
- medisana GmbH - Key offerings
- SWOT

15.13 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT

15.14 Murata Manufacturing Co. Ltd.
- Murata Manufacturing Co. Ltd. - Overview
- Murata Manufacturing Co. Ltd. - Business segments
- Murata Manufacturing Co. Ltd. - Key news
- Murata Manufacturing Co. Ltd. - Key offerings
- Murata Manufacturing Co. Ltd. - Segment focus
- SWOT

15.15 Nipro Corp.
- Nipro Corp. - Overview
- Nipro Corp. - Business segments
- Nipro Corp. - Key offerings
- Nipro Corp. - Segment focus
- SWOT

15.16 Prodigy Diabetes Care LLC
- Prodigy Diabetes Care LLC - Overview
- Prodigy Diabetes Care LLC - Product / Service
- Prodigy Diabetes Care LLC - Key offerings
- SWOT

15.17 Trivida Health Inc.
- Trivida Health Inc. - Overview
- Trivida Health Inc. - Product / Service
- Trivida Health Inc. - Key offerings
- SWOT

15.18 Ypsomed Holding AG
- Ypsomed Holding AG - Overview
- Ypsomed Holding AG - Business segments
- Ypsomed Holding AG - Key offerings
- Ypsomed Holding AG - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report

16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist

16.3 Currency conversion rates for US$
- Currency conversion rates for US$

16.4 Research methodology
- Research methodology

16.5 Data procurement
- Information sources

16.6 Data validation
- Data validation

16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing

16.8 Data synthesis
- Data synthesis

16.9 360 degree market analysis
- 360 degree market analysis

16.10 List of abbreviations
- List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES